NexTV Africa & Middle East

Complete News World

The third dose of the vaccine.  Boosters will bring pharma companies billions of extra dollars

The third dose of the vaccine. Boosters will bring pharma companies billions of extra dollars

polishing Ministry of Health He has already started issuing referrals for a booster vaccine. The third dose of the COVID-19 vaccine will be given to people over 50 and paramedics who have direct contact with the patient. From the beginning of September, referrals for the third dose vaccination are also issued for people with immune disorders

The United States has also taken a similar step. Health officials on Thursday recommended booster doses of the Pfizer vaccines to all Americans over 65, as well as to tens of millions of young adults who would qualify by occupation or medical condition.

a. Kutan: We can get COVID-19 vaccines every year

As I mentioned News agencyIn the coming weeks, this recommendation could be extended to booster doses of Moderna and Johnson & Johnson vaccines in the United States.

Analysts expect the value of boosters sold by Pfizer and BioNTech to be about $26 billion next year, and in the case of Moderna – $14 billion. Experts estimate that Pfizer/BioNTech’s profits from booster doses alone will be about $7 billion.

Watch the video
Is the national immunization program successful?

The EMA will announce its decision on the third dose

The European Medicines Agency will announce a decision on a possible third dose of a coronavirus vaccine early next month.

Immunity may decline over time after the second dose of the vaccine is given, said Marco Cavalieri, head of the EU agency’s vaccine evaluation team.

Vaccination against COVID-19 (illustrative image)Vaccinations against COVID-19 will be paid for. How long? Niedzielski translates

– For this reason, some Member States are already giving the third dose to selected groups to increase the immunity of people at risk during the winter season. The European Medicines Agency understands these decisions – the expert added.

See also  Deutsche Post begins strategic cooperation with data management provider The Adex

In early September, the EMA recommended a booster dose for people who are immunocompromised. A few days later, she received an order from the BioNTech and Pfizer consortium for a third dose, six months after the second dose was given to people over 16 years old.